Pejman Molaei

Pejman Molaei

Auto-generated profile, based on publicly available information

Pejman Molaei

Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2022 in Pathology - Research and Practice
Verified
Journal Article
Closed access
MFMojdeh Amini Faskhoudi
Mojdeh Amini Faskhoudi
PMPejman Molaei
Pejman Molaei
MSMehrdokht Sadrkhanloo
Mehrdokht Sadrkhanloo
SOSima Orouei
Sima Orouei
MHMehrdad Hashemi
Mehrdad Hashemi
MGMohammad Gholami
Mohammad Gholami


1 September 2022 in Pajouhan Scientific Journal
Verified
Journal Article
Open access
PDF file
MTMohammad Taheri
Mohammad Taheri
FKFatemeh Khavari
Fatemeh Khavari
PMPejman Molaei
Pejman Molaei
PHParisa Habibi
Parisa Habibi
FNFatemeh Nouri
Fatemeh Nouri
Background and Objectives: Acute lymphocytic leukemia (ALL) is a type of cancer that affects white blood cells. The disease progresses rapidly mandating immediate treatment. ALL is the most common type of leukemia affecting children. An increase in the miR-222-3p molecule has been observed in the course of this disease. The microarray ...

1 December 2023 in Neurodegenerative Disease Management
Verified
Journal Article
Closed access
MTMohammad Taheri
Mohammad Taheri
ABAli Bahrami
Ali Bahrami
KAKiana Kimiaei Asadi
Kiana Kimiaei Asadi
MMMojdeh Mohammadi
Mojdeh Mohammadi
PMPejman Molaei
Pejman Molaei
FNFatemeh Nouri
Fatemeh Nouri
Neuronal death, decreased activity or dysfunction of neurotransmitters are some of the pathophysiological reasons for neurodegenerative diseases like Alzheimer's, Parkinson's and multiple sclerosis...